Correlation Between Unicycive Therapeutics and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Genmab AS, you can compare the effects of market volatilities on Unicycive Therapeutics and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Genmab AS.
Diversification Opportunities for Unicycive Therapeutics and Genmab AS
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Genmab is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Genmab AS go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Genmab AS
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 3.69 times more return on investment than Genmab AS. However, Unicycive Therapeutics is 3.69 times more volatile than Genmab AS. It trades about 0.22 of its potential returns per unit of risk. Genmab AS is currently generating about -0.22 per unit of risk. If you would invest 40.00 in Unicycive Therapeutics on September 13, 2024 and sell it today you would earn a total of 40.00 from holding Unicycive Therapeutics or generate 100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Unicycive Therapeutics vs. Genmab AS
Performance |
Timeline |
Unicycive Therapeutics |
Genmab AS |
Unicycive Therapeutics and Genmab AS Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and Genmab AS
The main advantage of trading using opposite Unicycive Therapeutics and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Genmab AS vs. Ascendis Pharma AS | Genmab AS vs. Apellis Pharmaceuticals | Genmab AS vs. BeiGene | Genmab AS vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |